ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo radiotherapy in non-small cell lung cancer (NSCLC). (January 2020) - Lawless, C.; Hatton, M.; Faivre-Finn, C.; Pope, A.; Peedell, C.; Shaw, A.; McCartney, E.; Simoes, R.